A Randomized Pharmacogenetic Study of the Medication Topiramate in European-American Heavy Drinkers

A Randomized Pharmacogenetic Study of the Medication Topiramate in European-American Heavy Drinkers

Brief description of study

This is a 12-week, prospective, randomized clinical trial of the moderating effect of the gene rs2832407 on the efficacy of the medication topiramate in reducing drinking in 200 individuals of European descent with DSM-5 AUD. The investigators will compare the efficacy of topiramate to placebo in reducing drinking.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Alcoholism,Alcohol Use Disorder,Alcohol
  • Age: Between 18 Years - 70 Years
  • Gender: All
Updated on 14 Jul 2023. Study ID: 821035

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center